Caxton Associates LP Illumina, Inc. Transaction History

Caxton Associates LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$181.58 - $368.0 $666,761 - $1.35 Million	3,672 New	3,672 $677,000
Q4 2021 Feb 14, 2022	SELL	$347.28 - $421.83 $478,551 - $581,281	-1,378 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$405.61 - $524.84 $558,930 - $723,229	1,378 New	1,378 $559,000
Q2 2021 Aug 16, 2021	SELL	$372.84 - $481.5 $394,091 - $508,945	-1,057 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$361.28 - $504.76 $381,872 - $533,531	1,057 New	1,057 $406,000
Q1 2019 May 15, 2019	SELL	$272.57 - $321.18 $217,238 - $255,980	-797 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$272.46 - $366.54 $217,150 - $292,132	797 New	797 $239,000
Q3 2017 Nov 14, 2017	SELL	$172.3 - $213.93 $310,140 - $385,074	-1,800 Closed	0 $0
Q2 2017 Aug 29, 2017	BUY	N/A	1,800	1,800 $312,000

899

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

Stay updated on Caxton Associates LP with notifications on news.